Auckland, New Zealand - Bivalirudin (Angiomax? - The Medicines Company) should be considered as a new anticoagulant treatment option in patients with acute MI (AMI) treated with streptokinase, ...
CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with ...
SCAAR: Stent Thrombosis Risk After Primary PCI No Higher With Bivalirudin Than Other Antithrombotics
In a large, real-world population of STEMI patients, early stent thrombosis is equally rare regardless of whether bivalirudin, heparin, or a glycoprotein IIb/IIIa inhibitor (GPI) is used during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback